Multiscale biophysics · immune engineering

Immune Design · Molecule to Organoid

How does a T cell recognizing an antigen lead to clearing targets across a whole tissue? It has to pass three gates in a row. Receptor binding sets the input. A cooperative threshold turns that input into a switch-like T-cell decision. How easily effector cells get into the tissue sets how fast targets are cleared. Improving a stage helps only if it is the current bottleneck.

One 3D scene shows three scales at once. On the left, receptors bind antigen; in the center, a T cell turns a graded input into a switch-like decision; on the right, effector cells move into a tumor organoid and clear it. Change the parameters and find the scale that really holds the chain back.

Molecular occupancy

\theta

$0.90$

Cell activation

A

$0.95$

Organoid cleared

C

$0.0\%$

Clearance rate $0.21\,\mathrm{h}^{-1}$

Limiting scaleCascade open

Assay time $0.0\,\mathrm h$

This is a simplified teaching model of cause and effect. Binding is measured in effective surface units, the cell responds through a cooperative threshold, and the tissue outcome uses a mean clearance rate. It shows why a failure at one scale undoes the improvements made upstream; it cannot predict a patient's response or a dose.

Physics tutorial

How does one molecule reach a whole tissue?

BackgroundImmune engineering is not three independent problems. A receptor first contacts a target molecule. Networks inside the cell then turn that graded input into a single decision: activate or stay silent. Tissue is cleared on a large scale only when activated effector cells get into it and kill target cells one after another.

Why it mattersThis is why making a receptor “stickier” does not guarantee success. Too little antigen, a strong checkpoint brake or poor access to the tissue can each drive the whole chain to zero.

Start with the essentials

Focus question: Which scale limits final clearance? When does a better molecular design upstream help, and when is its gain lost in a bottleneck downstream?
One-sentence intuition: A multiscale design has to improve the product of every step in the chain, not maximize one step alone. Receptor occupancy provides the input, a cooperative threshold turns it into a cell decision, and access to the tissue sets the final clearance rate.

Core mathematical model

Receptor occupancy

\theta=\frac{\rho_A}{\rho_A+K_D^\ast}

Antigen presentation and the half-saturation level are both in effective surface units. More antigen, or a lower effective half-saturation, raises occupancy. This is a simplified teaching map: binding on a membrane is not treated as a concentration in solution.

Cooperative threshold in the cell

A=\frac{\left[(1-b)\theta\right]^n}{\left[(1-b)\theta\right]^n+\tau^n}

The checkpoint brake $b$ first weakens the input. The cooperativity $n$ then sharpens a smooth molecular change into a steep, almost on-off cell decision.

Tissue clearance

C(t)=1-\exp\!\left[-k_{\max}A\,\frac{R_{E:T}}{R_{E:T}+R_{1/2}}\,t\right]

The organoid layer multiplies the activation by how well effector cells reach the tissue, which gives a mean clearance rate. Real tissue also involves migration, exhaustion, spatial barriers and clonal differences; this equation keeps only the key structure of steps in series.

Common difficulties

Higher affinity is not the same as better therapy

Typical misconceptionIf the receptor binds strongly enough, the tissue has to be cleared.

Better mental modelBinding opens only the first gate. Checkpoints, signaling thresholds, infiltration and the number of effector cells all come after it. If any one of them closes, the gain upstream never reaches the tissue.

This is not a patient digital twin

Typical misconceptionReal assay values entered into the sliders would predict one patient’s response.

Better mental modelThe Lab squeezes complex processes into a few dimensionless parameters so that causes and bottlenecks are easy to see. It is not trained or calibrated on clinical outcomes and cannot guide diagnosis, dosing or treatment.

Run the experiment

01
Create immune escape
Choose Immune escape and see which of the three worlds dims first.
What to observe: Low antigen and weak binding cut molecular occupancy first, and cell signaling and organoid clearance shut down after it.
02
Fix only the receptor
Choose Receptor redesign, then gradually raise the checkpoint brake.
What to observe: Binding on the left stays bright, but the cell decision in the center switches off suddenly at its threshold, and tissue clearance disappears with it.
03
Open the whole chain
Choose Checkpoint rescue, then lower the effector ratio.
What to observe: The molecular and cellular gates stay open, but the bottleneck moves to tissue access. Raising the effector ratio again makes the organoid collapse.